Log In
Print this Print this

oral H1N1 influenza vaccine (VXA-A1.1)

  Manage Alerts
Collapse Summary General Information
Company Vaxart Inc.
DescriptionOral, monovalent vaccine against the H1N1 influenza virus
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationInfluenza virus
Indication DetailsVaccinate against H1N1 influenza virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today